1 Cinatl, J., Jr., "The threat of avian influenza A (H5N1). Part IV: Development of vaccines" 196 : 213-225, 2007
2 Ada, G.L., "The immune response to influenza infection" 128 : 1-54, 1986
3 Tuerk, C., "Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase" 249 : 505-510, 1990
4 Weis, W., "Structure of the influenza virus haemagglutinin complexed with its receptor,sialic acid" 333 : 426-431, 1988
5 Wilson, I.A., "Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution" 289 : 366-373, 1981
6 Wilson, I.A., "Structural basis of immune recognition of influenza virus hemagglutinin" 8 : 737-771, 1990
7 Skehel, J.J., "Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin" 69 : 531-569, 2000
8 Jürgen Roth, "Protein N-Glycosylation, Protein Folding, and Protein Quality Control" 한국분자세포생물학회 30 (30): 496-506, 2010
9 Cheng, C., "Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX" 366 : 670-674, 2008
10 Sorrell, E.M., "Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus" 106 : 7565-7570, 2009
1 Cinatl, J., Jr., "The threat of avian influenza A (H5N1). Part IV: Development of vaccines" 196 : 213-225, 2007
2 Ada, G.L., "The immune response to influenza infection" 128 : 1-54, 1986
3 Tuerk, C., "Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase" 249 : 505-510, 1990
4 Weis, W., "Structure of the influenza virus haemagglutinin complexed with its receptor,sialic acid" 333 : 426-431, 1988
5 Wilson, I.A., "Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution" 289 : 366-373, 1981
6 Wilson, I.A., "Structural basis of immune recognition of influenza virus hemagglutinin" 8 : 737-771, 1990
7 Skehel, J.J., "Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin" 69 : 531-569, 2000
8 Jürgen Roth, "Protein N-Glycosylation, Protein Folding, and Protein Quality Control" 한국분자세포생물학회 30 (30): 496-506, 2010
9 Cheng, C., "Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX" 366 : 670-674, 2008
10 Sorrell, E.M., "Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus" 106 : 7565-7570, 2009
11 Zuker, M., "Mfold web server for nucleic acid folding and hybridization prediction" 31 : 3406-3415, 2003
12 Park, M., "Interaction of DNA Aptamers with Avian Influenza Virus H9 peptide" 9 : 10-, 2008
13 Lipatov, A.S., "Influenza: emergence and control" 78 : 8951-8959, 2004
14 Jeon, S.H., "Immunization with influenza virus hemagglutinin globular region containing the receptor-binding pocket" 15 : 165-176, 2002
15 Lu, X., "Immunity to influenza A H9N2 viruses induced by infection and vaccination" 75 : 4896-4901, 2001
16 Gao, X.M., "Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus" 143 : 3007-3014, 1989
17 Peiris, M., "Human infection with influenza H9N2" 354 : 916-917, 1999
18 Virelizier, J.L., "Host defenses against influenza virus: the role of anti-hemagglutinin antibody" 115 : 434-439, 1975
19 Matrosovich, M.N., "H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity" 281 : 156-162, 2001
20 Sorrell, E.M., "Genesis of pandemic influenza" 117 : 394-402, 2007
21 Du, N., "Generation and evaluation of the trivalent inactivated reassortant vaccine using human,avian,and swine influenza A viruses" 26 : 2912-2918, 2008
22 He, Q., "Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody" 14 : 617-623, 2007
23 Shamah, S.M., "Complex target SELEX" 41 : 130-138, 2008
24 Wu, R., "Characterization of a pathogenic H9N2 influenza A virus isolated from central China in 2007" 153 : 1549-1555, 2008
25 Fouchier, R.A., "Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls" 79 : 2814-2822, 2005
26 Lin, Y.P., "Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates" 97 : 9654-9658, 2000
27 Thomas, J.K., "Avian influenza: a review" 64 : 149-165, 2007
28 Homme, P.J., "Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus" 14 : 66-74, 1970
29 Wong, S.S., "Avian influenza virus infections in humans" 129 : 156-168, 2006
30 James, W., "Aptamers in the virologists’ toolkit" 88 : 351-364, 2007
31 Jun Gu Choi, "An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea" 대한수의학회 9 (9): 67-74, 2008
32 Gopinath, S.C., "An efficient RNA aptamer against human influenza B virus hemagglutinin" 139 : 837-846, 2006
33 Gopinath, S.C., "An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion" 87 : 479-487, 2006
34 Wan, H., "Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells" 81 : 5181-5191, 2007
35 Klug, S.J., "All you wanted to know about SELEX" 20 : 97-107, 1994
36 Alexander, M.E., "A delay differential model for pandemic influenza with antiviral treatment" 70 : 382-397, 2008
37 Jeon, S.H., "A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin" 279 : 48410-48419, 2004